BACKGROUND: The global epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) is heterogeneous. The objective of this study was to evaluate MRSA epidemiology in Switzerland over an 11-year period. METHODS: We conducted a retrospective study with time series analysis on S. aureus including MRSA and non-multidrug resistant MRSA (NmMRSA). We used NmMRSA as a marker for community-acquired MRSA. NmMRSA was defined as MRSA susceptible to at least three of the following agents: ciprofloxacin, clindamycin, tetracycline and trimethoprim-sulfamethoxazole. RESULTS: A total of 14 648 MRSA and 115 917 methicillin-susceptible S. aureus (MSSA) isolates were included. Despite an overall decrease of the proportion of MRSA among S. aureus clinical isolates (from 14% in 2004 to 8% in 2014), an increasing trend in NmMRSA was observed. Variations in geographical distribution were noted, with a decrease in the proportion of MRSA in the Italian- and French-speaking regions (from 20-26% in 2004 to 12% in 2014) and low prevalence (3-5%) in the German-speaking region. We noticed an increase in the proportion of MRSA in outpatients (+0.03% per quarter per year) and in the younger population (+0.05% per quarter per year) compared with a decreasing trend in inpatients and the elderly. CONCLUSION: The proportion of MRSA among S. aureus isolates in Switzerland decreased overall from 2004 to 2014. Worrisome increases of NmMRSA were found in younger persons and outpatients.
BACKGROUND: The global epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) is heterogeneous. The objective of this study was to evaluate MRSA epidemiology in Switzerland over an 11-year period. METHODS: We conducted a retrospective study with time series analysis on S. aureus including MRSA and non-multidrug resistant MRSA (NmMRSA). We used NmMRSA as a marker for community-acquired MRSA. NmMRSA was defined as MRSA susceptible to at least three of the following agents: ciprofloxacin, clindamycin, tetracycline and trimethoprim-sulfamethoxazole. RESULTS: A total of 14 648 MRSA and 115 917 methicillin-susceptible S. aureus (MSSA) isolates were included. Despite an overall decrease of the proportion of MRSA among S. aureus clinical isolates (from 14% in 2004 to 8% in 2014), an increasing trend in NmMRSA was observed. Variations in geographical distribution were noted, with a decrease in the proportion of MRSA in the Italian- and French-speaking regions (from 20-26% in 2004 to 12% in 2014) and low prevalence (3-5%) in the German-speaking region. We noticed an increase in the proportion of MRSA in outpatients (+0.03% per quarter per year) and in the younger population (+0.05% per quarter per year) compared with a decreasing trend in inpatients and the elderly. CONCLUSION: The proportion of MRSA among S. aureus isolates in Switzerland decreased overall from 2004 to 2014. Worrisome increases of NmMRSA were found in younger persons and outpatients.
Authors: Annette Jurke; Inka Daniels-Haardt; Welmoed Silvis; Matthijs S Berends; Corinna Glasner; Karsten Becker; Robin Köck; Alex W Friedrich Journal: Euro Surveill Date: 2019-04
Authors: Pascal M Frey; Grischa R Marti; Sara Droz; Mirjam de Roche von Arx; Franziska Suter-Riniker; Drahomir Aujesky; Silvio D Brugger Journal: Antimicrob Resist Infect Control Date: 2019-06-06 Impact factor: 4.887
Authors: R Fulchini; W C Albrich; A Kronenberg; A Egli; C R Kahlert; M Schlegel; P Kohler Journal: Epidemiol Infect Date: 2019-08-30 Impact factor: 2.451
Authors: Oluwaseun Rume-Abiola Oyewole; Phung Lang; Werner C Albrich; Kerstin Wissel; Stephen L Leib; Carlo Casanova; Markus Hilty Journal: Microorganisms Date: 2021-05-18
Authors: Philipp Kohler; Rosamaria Fulchini; Werner C Albrich; Adrian Egli; Carlo Balmelli; Stephan Harbarth; Delphine Héquet; Christian R Kahlert; Stefan P Kuster; Christiane Petignat; Matthias Schlegel; Andreas Kronenberg Journal: Antimicrob Resist Infect Control Date: 2018-07-20 Impact factor: 4.887
Authors: C Landelle; V Nocquet Boyer; M Abbas; E Genevois; N Abidi; S Naimo; R Raulais; L Bouchoud; F Boroli; H Terrisse; J-L Bosson; S Harbarth; J Pugin Journal: Intensive Care Med Date: 2018-10-21 Impact factor: 17.440